{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:11:16Z","timestamp":1758121876503},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.vaccine.2004.06.003","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T21:39:35Z","timestamp":1090964375000},"page":"343-352","source":"Crossref","is-referenced-by-count":11,"title":["Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes"],"prefix":"10.1016","volume":"23","author":[{"given":"Nina-Maria","family":"Vasconcelos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu Bakar","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Ahlborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klavs","family":"Berzins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.vaccine.2004.06.003_bib1","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","article-title":"Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system","volume":"85","author":"Tam","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0065-2776(08)60585-4","article-title":"The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases","volume":"60","author":"Nardin","year":"1995","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0264-410X(97)00155-2","article-title":"Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation","volume":"16","author":"Ahlborg","year":"1998","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2004.06.003_bib4","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.4049\/jimmunol.149.7.2385","article-title":"Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes","volume":"149","author":"Chai","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.171.1.299","article-title":"Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria","volume":"171","author":"Tam","year":"1990","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev.iy.11.040193.003351","article-title":"T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages","volume":"11","author":"Nardin","year":"1993","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-3024.1991.tb00272.x","article-title":"Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions","volume":"13","author":"Burkot","year":"1991","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.132.2.909","article-title":"Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies","volume":"132","author":"Hollingdale","year":"1984","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.vaccine.2004.06.003_bib9","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/eji.1830211217","article-title":"Immunogenicity of multiple antigen peptides (MAP) containing T- and B-cell epitopes of the repeat region of the P. falciparum circumsporozoite protein","volume":"21","author":"Munesinghe","year":"1991","journal-title":"Eur. J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.06.003_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-1759(93)90159-5","article-title":"In vitro phagocytosis inhibition assay for the screening of potential candidate antigens for sub-unit vaccines against the asexual blood stage of Plasmodium falciparum","volume":"159","author":"Gysin","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.vaccine.2004.06.003_bib11","unstructured":"Berzins K, Perlmann P. Malaria vaccines: attacking infected erythrocytes. In: Hoffman SL, editor. Malaria Vaccine Development: A Multi-Immune Response Approach. Washington: American Society for Microbiology Press; 1996. p. 105\u201343."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0166-6851(91)90202-H","article-title":"Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2","volume":"46","author":"Ahlborg","year":"1991","journal-title":"Mol. Biochem. Parasitol."},{"issue":"10","key":"10.1016\/j.vaccine.2004.06.003_bib13","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.4049\/jimmunol.142.10.3620","article-title":"Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens","volume":"142","author":"Udomsangpetch","year":"1989","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2004.06.003_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2567.1996.d01-688.x","article-title":"Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332","volume":"88","author":"Ahlborg","year":"1996","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2004.06.003_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0161-5890(97)00046-1","article-title":"Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332","volume":"34","author":"Ahlborg","year":"1997","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.vaccine.2004.06.003_bib16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/eji.1830191209","article-title":"Universally immunogenic T-cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells","volume":"19","author":"Panina-Bordignon","year":"1989","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4049\/jimmunol.149.2.717","article-title":"Use of human universally antigenic tetanus toxin T-cell epitopes as carriers for human vaccination","volume":"149","author":"Valmori","year":"1992","journal-title":"J. Immunol."},{"issue":"6201","key":"10.1016\/j.vaccine.2004.06.003_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/336778a0","article-title":"A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules","volume":"336","author":"Sinigaglia","year":"1988","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2004.06.003_bib19","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4049\/jimmunol.159.3.1362","article-title":"Binding of malaria T-cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T-cell epitope in the Plasmodium falciparum circumsporozoite protein","volume":"159","author":"Calvo-Calle","year":"1997","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-1759(94)00328-T","article-title":"Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry","volume":"179","author":"Ahlborg","year":"1995","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2004.06.003_bib21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"issue":"5","key":"10.1016\/j.vaccine.2004.06.003_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2307\/3279900","article-title":"Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle jar method","volume":"63","author":"Jensen","year":"1977","journal-title":"J. Parasitol."},{"issue":"7","key":"10.1016\/j.vaccine.2004.06.003_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-3024.1995.tb00901.x","article-title":"Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence","volume":"17","author":"Ahlborg","year":"1995","journal-title":"Parasite Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2004.06.003_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/expr.1994.1091","article-title":"Plasmodium falciparum: the Pf332 antigen is secreted from the parasite by a brefeldin A-dependent pathway and is translocated to the erythrocyte membrane via the Maurer\u2019s clefts","volume":"79","author":"Hinterberg","year":"1994","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.vaccine.2004.06.003_bib25","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/IAI.68.4.2102-2109.2000","article-title":"Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1[19]) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19)","volume":"68","author":"Ahlborg","year":"2000","journal-title":"Infect. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4049\/jimmunol.166.1.481","article-title":"A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T-cell epitopes elicits immune responses in volunteers of diverse HLA types","volume":"166","author":"Nardin","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002371-200003000-00010","article-title":"Detection of T-helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma","volume":"23","author":"Ressing","year":"2000","journal-title":"J. Immunother."},{"issue":"5","key":"10.1016\/j.vaccine.2004.06.003_bib28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.148.5.1499","article-title":"\u201cUniversal\u201d T-helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide","volume":"148","author":"Kumar","year":"1992","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.vaccine.2004.06.003_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/intimm\/3.10.997","article-title":"Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein","volume":"3","author":"Moreno","year":"1991","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0141-9838.2001.00440.x","article-title":"Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2","volume":"24","author":"Ndungu","year":"2002","journal-title":"Parasite Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1471-4906(02)00012-1","article-title":"Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design","volume":"24","author":"Garraud","year":"2003","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1084\/jem.182.2.409","article-title":"Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages","volume":"182","author":"Bouharoun-Tayoun","year":"1995","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0022-1759(83)90430-1","article-title":"Assessment of immune phagocytosis of Plasmodium falciparum infected red blood cells by human monocytes and polymorphonuclear leukocytes","volume":"63","author":"Celada","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/expr.2001.4619","article-title":"Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro","volume":"98","author":"Tebo","year":"2001","journal-title":"Exp. Parasitol."},{"issue":"10","key":"10.1016\/j.vaccine.2004.06.003_bib35","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.166.10.6236","article-title":"A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection","volume":"166","author":"Yoneto","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2004.06.003_bib36","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.4049\/jimmunol.154.4.1762","article-title":"Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants","volume":"154","author":"Hunter","year":"1995","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2004.06.003_bib37","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.168.3.1348","article-title":"IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice","volume":"168","author":"Su","year":"2002","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.vaccine.2004.06.003_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-3024.2001.00419.x","article-title":"Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab\u2019)2 fragments","volume":"23","author":"Cavinato","year":"2001","journal-title":"Parasite Immunol."},{"issue":"8","key":"10.1016\/j.vaccine.2004.06.003_bib39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00932945","article-title":"Immunoglobulin G2a isotype may have a protective role in Plasmodium berghei NK65 infection in immunised mice","volume":"80","author":"Akanmori","year":"1994","journal-title":"Parasitol. Res."},{"issue":"10","key":"10.1016\/j.vaccine.2004.06.003_bib40","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/IAI.59.10.3547-3554.1991","article-title":"Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii","volume":"59","author":"White","year":"1991","journal-title":"Infect. Immunol."},{"issue":"10","key":"10.1016\/j.vaccine.2004.06.003_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-3024.1995.tb00880.x","article-title":"Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice","volume":"17","author":"Waki","year":"1995","journal-title":"Parasite Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.06.003_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.15.1.297","article-title":"Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches","volume":"15","author":"Constant","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.06.003_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03401734","article-title":"Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration","volume":"4","author":"Gramzinski","year":"1998","journal-title":"Mol. Med."},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2004.06.003_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-409X(01)00169-7","article-title":"Manipulating the immune system: humoral versus cell-mediated immunity","volume":"51","author":"McNeela","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.vaccine.2004.06.003_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/intimm\/9.4.523","article-title":"In vivo induction of type 1 and 2 immune responses against protein antigens","volume":"9","author":"Comoy","year":"1997","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.vaccine.2004.06.003_bib46","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/IAI.64.7.2602-2608.1996","article-title":"Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection","volume":"64","author":"Daly","year":"1996","journal-title":"Infect. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2004.06.003_bib47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-3083.1984.tb00923.x","article-title":"Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo","volume":"19","author":"Hadjipetrou-Kourounakis","year":"1984","journal-title":"Scand. J. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2004.06.003_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0264-410X(97)00165-5","article-title":"Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants","volume":"16","author":"Le","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2004.06.003_bib49","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.69.8.4884-4890.2001","article-title":"Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates","volume":"69","author":"Joshi","year":"2001","journal-title":"Infect. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04004669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04004669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:00:38Z","timestamp":1682737238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04004669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0264410X04004669"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}